"Fundación para la investigación en Neurociencias"

During the past decade, Fundación CENIT para la Investigación en Neurociencias conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 10 clinical trials were completed, i.e. on average, 34.5% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 9 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fundación CENIT para la Investigación en Neurociencias" #1 sponsor was "Hoffmann-La Roche" with 22 trials, followed by "Eli Lilly and Company" with 7 trials sponsored, "CureVac" with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored and "Loxo Oncology, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fundación CENIT para la Investigación en Neurociencias" #1 collaborator was "Chugai" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Exelixis" with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Fundación CENIT para la Investigación en Neurociencias" are "Non-Small Cell Lung Cancer" (5 trials), "Breast Neoplasms" (4 trials), "Early Breast Cancer" (3 trials), "Neoplasm Metastasis" (3 trials) and "Breast Cancer" (2 trials). Many other conditions were trialed in "Fundación CENIT para la Investigación en Neurociencias" in a lesser frequency.

Most popular intervention types in "Fundación CENIT para la Investigación en Neurociencias" are "Drug" (32 trials), "Procedure" (2 trials), "Radiation" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (9 trials), "Placebo" (8 trials), "Paclitaxel" (6 trials), "Abemaciclib" (5 trials) and "Carboplatin" (5 trials). Other intervention names were less common.

The vast majority of trials in "Fundación CENIT para la Investigación en Neurociencias" are 32 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Fundación CENIT para la Investigación en Neurociencias". undefined are not yet recruiting, 12 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Fundación CENIT para la Investigación en Neurociencias, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Fundación CENIT para la Investigación en Neurociencias, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".